感染監視ソリューション市場：ソフトウェア（オンプレミス、Webベース）、サービス（製品サポート＆メンテナンス、導入、トレーニング＆コンサルティング）、エンドユーザー（病院、長期療養施設）、地域別-2027年までの世界予測

Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027

感染監視ソリューション市場は、2022年の推定577百万米ドルから2027年には1,100百万米ドルまで、予測期間中に13.8%のCAGRで成長すると予測されます。同市場は、院内感染の増加、外科手術の増加、医療費の増加など... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年2月15日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	258	294	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

感染監視ソリューション市場は、2022年の推定577百万米ドルから2027年には1,100百万米ドルまで、予測期間中に13.8%のCAGRで成長すると予測されます。同市場は、院内感染の増加、外科手術の増加、医療費の増加などの要因による需要の増加により、有望な成長ポテンシャルを有しています。しかし、熟練した医療IT専門家の不足とデータセキュリティの懸念が、この市場の成長を一定程度制限すると予想されます。「トレーニング＆コンサルティングサービス感染症サーベイランスサービス市場において最も成長が著しい分野（タイプ別）」感染症サーベイランスサービス市場において、予測期間中に最も成長が著しいのは、トレーニング＆コンサルティングサービスであると予想されます。トレーニングおよびコンサルティングサービスは、市場で入手可能な最新の感染監視ソリューションに対する医療従事者の認知度を高めるものです。大手および中堅企業の多くは、感染監視ソフトウェアを使用している病院、独立系ラボ、医院のラボに対して積極的に技術支援を行っています。バリューベースドケアの重要性の高まり、技術の進歩、ヘルスケアにおける統合の進展などの要因が、コンサルティングサービスの市場を牽引しています。「予測期間中、病院のタイプ別感染監視ソリューション市場は大病院が最大と予測」タイプ（病床数）に基づき、病院は大規模病院（450床以上）、中規模病院（250～449床）、小規模（249床未満）に区分される。病院向け感染監視ソリューション市場では、大規模病院部門が最大のシェアを占めています。中国やその他の発展途上国では私立病院が増加しており、ICUや病院のその他の部門に導入される技術的に高度なHCITソリューションの需要を促進すると予想されます。さらに、病院の規模が大きくなるほど、より多くの患者を継続的に監視する必要があるため、HAI管理の複雑さが増し、これがこのエンドユーザー分野のシェアが高い主な理由です。"予測期間中、感染監視ソリューション市場で欧州が第2位のシェアを占める予測期間中、感染監視ソリューション市場で欧州が第2位のシェアを占めている。欧州市場の成長の背景には、HCITソリューションの導入拡大、HAIの発生率の増加、手術件数の増加、老年人口の増加などがあります。患者の転帰を改善する必要性が高まっていることが、この地域全体で感染監視ソリューションの導入に寄与しています。欧州では、病院や長期療養施設の感染予防戦略として、いくつかの政策やガイドラインが実施されており、これが同地域の感染監視ソリューションの需要を促進している。企業タイプ別：Tier 1-40%, Tier 2-35%, Tier 3-25% ●役職別：Cレベル35%, ディレクターレベル25%, その他40% ●地域別：北米45%, 欧州30%, アジア太平洋20%, 中南米3%, 中東・アフリカ2%感染監視ソリューション市場の主要プレイヤー感染監視ソリューション市場で活動している主要プレイヤーは、Becton、Dickinson and Company (US), Premier, Inc.(米国）、Wolters Kluwer N.V.（オランダ）、Cerner Corporation（米国）、Baxter International Inc.（米国）、GOJO Industries, Inc.（米国）、Clinisys（米国）、Deb Group Ltd. （英国）、BioVigil Inc.(英国）、BioVigil Healthcare Systems（米国）、RLDatix（英国）、Merative（米国）、Vecna Technologies, Inc.（米国）、VigiLanz Corporation（米国）、Ecolab（米国）、Harris Healthcare（米国）、PeraHealth（米国）、Medexter Healthcare（オーストリア）、CenTrak、Inc（米国）、bioMerieux SA（フランス）、CKM Healthcare （カナダ）、Asolva Inc.(米国）、PointClickCare（カナダ）、STANLEY Healthcare（米国）、Vitalacy Inc.（米国）、VIZZIA Technologies（米国）。調査範囲：この調査レポートは、感染監視ソリューション市場を分析し、製品・サービス、エンドユーザー、地域などの様々なセグメントに基づいて、この市場の市場規模および将来の成長可能性を推定することを目指しています。また、市場で入手可能な様々な感染監視ソリューション製品＆サービスの製品ポートフォリオマトリックスも掲載しています。また、本レポートでは、本市場における主要企業の競争分析も行っており、企業プロファイル、製品提供、主要な市場戦略も併せて掲載しています。本レポートを購入する理由本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握するのに役立ち、ひいては、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入された企業は、下記の戦略の1つまたは任意の組み合わせを使用して、市場での地位を強化することができます： - 市場浸透：市場浸透度：世界の感染監視ソリューション市場の上位企業が提供する製品ポートフォリオに関する包括的な情報を提供します。本レポートでは、この市場を製品・サービス別、エンドユーザー別に分析しています●製品の強化・革新：製品の強化/革新：世界の感染監視ソリューション市場における今後の動向や製品の発売に関する詳細な洞察 - 市場開拓：市場開拓：製品・サービス別、エンドユーザー別の有利な新興市場に関する包括的な情報 - 市場の多様化：感染監視ソリューションの世界市場における新製品や製品強化、成長地域、最近の開発、投資などに関する詳細な情報を提供します：感染症監視ソリューションの世界市場における主要企業の市場シェア、成長戦略、製品提供、競争力のマッピング、能力を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS 35
1.3 MARKET SEGMENTATION 35
FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 36
1.6 STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 37
1.8 RECESSION IMPACT 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN 40
2.2 RESEARCH METHODOLOGY DESIGN 41
2.2.1 SECONDARY RESEARCH 42
2.2.1.1 Key data from secondary sources 43
2.2.2 PRIMARY DATA 43
FIGURE 3 PRIMARY SOURCES 44
2.2.2.1 Key data from primary sources 45
2.2.2.2 Key insights from primary experts 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET 47
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 48
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 49
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 9 CAGR PROJECTIONS 52
FIGURE 10 TOP-DOWN APPROACH 52
2.4 DATA TRIANGULATION APPROACH 54
FIGURE 11 DATA TRIANGULATION METHODOLOGY 54
2.5 MARKET SHARE ESTIMATION 55
2.6 ASSUMPTIONS FOR THE STUDY 55

2.7 LIMITATIONS 56
2.7.1 METHODOLOGY-RELATED LIMITATIONS 56
2.7.2 SCOPE-RELATED LIMITATIONS 56
2.8 RISK ASSESSMENT 56
TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET 56
3 EXECUTIVE SUMMARY 57
FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 57
FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 58
FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 59
FIGURE 16 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 2021 60
4 PREMIUM INSIGHTS 61
4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW 61
FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH 61
4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY 62
FIGURE 18 HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021 62
4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63
FIGURE 19 CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 2027 63
4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020–2027) 64
FIGURE 20 NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD 64
4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS 64
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET 65
5.2.1 MARKET DRIVERS 66
5.2.1.1 Increasing prevalence of hospital-acquired infections 66
5.2.1.2 Increasing adoption of antimicrobial stewardship programs 67
5.2.1.3 Increasing number of surgeries 67
TABLE 4 US: PERCENTAGE INCREASE IN SURGICAL VOLUMES 67
5.2.1.4 Growing geriatric population and increasing incidence of chronic diseases 68
5.2.1.5 Growing investments to improve healthcare systems 69
5.2.2 MARKET RESTRAINTS 69
5.2.2.1 High cost of deployment for small healthcare organizations 69
TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2021 70
5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions 70
5.2.3 MARKET OPPORTUNITIES 71
5.2.3.1 Increasing consolidation in healthcare industry 71
5.2.3.2 Cloud-based software solutions 71
5.2.3.3 Emerging markets 71
5.2.4 MARKET CHALLENGES 72
5.2.4.1 Shortage of skilled healthcare IT professionals 72
5.2.4.2 Data security concerns 72
6 INDUSTRY TRENDS 73
6.1 INTRODUCTION 73
6.2 INDUSTRY TRENDS 73
6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS 73
6.2.2 AI-POWERED SURVEILLANCE SOFTWARE 73
6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES 74
6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS 74
6.3 REGULATORY ANALYSIS 74
6.3.1 NORTH AMERICA 74
TABLE 6 NORTH AMERICA: REGULATIONS AND LAWS 75
6.3.2 EUROPE 76
TABLE 7 EUROPE: REGULATIONS AND LAWS 76
6.3.3 ASIA 77
TABLE 8 ASIA: REGULATIONS AND LAWS 77
6.3.4 MIDDLE EAST & AFRICA 78
TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS AND LAWS 78
6.3.5 LATIN AMERICA 78
TABLE 10 LATIN AMERICA: REGULATIONS AND LAWS 78
TABLE 11 KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS 79
6.4 TECHNOLOGY ANALYSIS 80
6.4.1 CLOUD COMPUTING TECHNOLOGY 80
6.4.2 ARTIFICIAL INTELLIGENCE 80
TABLE 12 AI IN HEALTHCARE MARKET, BY REGION, 2017–2020 (USD MILLION) 80
TABLE 13 AI IN HEALTHCARE MARKET, BY REGION, 2021–2027 (USD MILLION) 81
6.4.3 BLUETOOTH LOW-ENERGY SENSORS 81
6.5 ECOSYSTEM ANALYSIS 81
FIGURE 22 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 82
6.6 PATENT ANALYSIS 82
6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS 82
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023) 83
6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 83
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012– JANUARY 2023) 84
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012–JANUARY 2023) 85
TABLE 14 INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2022 85
6.7 IMPACT OF RECESSION 88
7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE 89
7.1 INTRODUCTION 90
TABLE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 90
7.2 SOFTWARE 90
TABLE 16 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 17 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.1 ON-PREMISE SOFTWARE 93
7.2.1.1 Data protection and in-house access to HCIT solutions to drive market 93
TABLE 18 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 93
TABLE 19 ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.2 WEB-BASED SOFTWARE 95
7.2.2.1 Increasing demand for data centralization and cost-benefits of solutions to drive adoption 95
TABLE 20 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS 95
TABLE 21 WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.3 SERVICES 97
TABLE 22 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 23 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
7.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES 98
7.3.1.1 Rising reliance on outsourcing HCIT support to boost demand 98
TABLE 24 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
7.3.2 TRAINING & CONSULTING SERVICES 100
7.3.2.1 Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities 100
TABLE 25 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
7.3.3 IMPLEMENTATION SERVICES 101
7.3.3.1 Focus on ensuring regulatory compliance among end users to boost service sector growth 101
TABLE 26 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER 102
8.1 INTRODUCTION 103
TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 103
8.2 HOSPITALS 103
TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 104
8.2.1 LARGE HOSPITALS 105
8.2.1.1 Growing need to deploy cloud-based solutions to drive growth 105
TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 105
8.2.2 MEDIUM-SIZED HOSPITALS 106
8.2.2.1 Increasing demand for more specialized and advanced care to boost market 106
TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 106
8.2.3 SMALL HOSPITALS 107
8.2.3.1 Need to decrease operational costs and growing competition to support adoption 107
TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.3 LONG-TERM CARE FACILITIES 108
TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 109
8.3.1 NURSING HOMES 109
8.3.1.1 Growing geriatric population to favor end-user growth 109
TABLE 35 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020–2027 (USD MILLION) 110
8.3.2 SKILLED NURSING FACILITIES 110
8.3.2.1 Advancements in HCIT solutions to favor adoption in SNFs 110
TABLE 36 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 111
8.3.3 ASSISTED LIVING FACILITIES 111
8.3.3.1 ALFs to show significant growth alongside rising geriatric population 111
TABLE 37 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 112
8.4 OTHER END USERS 112
TABLE 38 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 113
9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION 114
9.1 INTRODUCTION 115
FIGURE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020–2027) 115
TABLE 39 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 116
9.2 NORTH AMERICA 116
9.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 117
FIGURE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 117
TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 118
TABLE 42 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 43 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 44 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 119
TABLE 45 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 46 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 120
9.2.2 US 120
9.2.2.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth 120
TABLE 47 US: KEY MACROINDICATORS 121
TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 121
TABLE 49 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 50 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 51 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
TABLE 52 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 53 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 123
9.2.3 CANADA 123
9.2.3.1 Rising adoption of advanced HCIT solutions to propel market growth 123
TABLE 54 CANADA: KEY MACROINDICATORS 124
TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 125
TABLE 56 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 57 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 58 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
TABLE 59 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 60 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 126
9.3 EUROPE 127
9.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION 127
TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 128
TABLE 63 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 64 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 65 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
TABLE 66 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 67 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 130
9.3.2 GERMANY 130
9.3.2.1 Germany to hold largest share of European market 130
TABLE 68 GERMANY: KEY MACROINDICATORS 131
TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 131
TABLE 70 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 71 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 72 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
TABLE 73 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 74 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 133
9.3.3 FRANCE 133
9.3.3.1 High healthcare spending and favorable government initiatives to drive market growth in France 133
TABLE 75 FRANCE: KEY MACROINDICATORS 134
TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 77 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 78 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 79 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
TABLE 80 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 81 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 136
9.3.4 UK 136
9.3.4.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK 136
TABLE 82 UK: KEY MACROINDICATORS 137
TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 84 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 85 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 86 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 138
TABLE 87 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 88 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 139
9.3.5 ITALY 139
9.3.5.1 Increasing adoption of eHealth technologies to propel market growth in Italy 139
TABLE 89 ITALY: KEY MACROINDICATORS 140
TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 140
TABLE 91 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 92 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 93 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
TABLE 94 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 95 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 142
9.3.6 SPAIN 142
9.3.6.1 Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth 142
TABLE 96 SPAIN: KEY MACROINDICATORS 143
TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 143
TABLE 98 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 99 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 100 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 144
TABLE 101 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 102 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 145
9.3.7 SWITZERLAND 145
9.3.7.1 Increasing demand for healthcare services and growing healthcare awareness to augment market 145
TABLE 103 SWITZERLAND: KEY MACROINDICATORS 146
TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 105 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 106 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 107 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 147
TABLE 108 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 109 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 148
9.3.8 NETHERLANDS 148
9.3.8.1 Increasing healthcare initiatives to favor demand growth 148
TABLE 110 NETHERLANDS: KEY MACROINDICATORS 149
TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 112 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 113 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 114 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 150
TABLE 115 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 116 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 151
9.3.9 REST OF EUROPE 151
TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 152
TABLE 118 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 119 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 120 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 153
TABLE 121 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 122 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 153
9.4 ASIA PACIFIC 154
9.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 154
FIGURE 29 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 155
TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 156
TABLE 125 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 126 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 127 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 157
TABLE 128 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 129 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 158
9.4.2 JAPAN 158
9.4.2.1 Japan to dominate APAC market over forecast period 158
TABLE 130 JAPAN: KEY MACROINDICATORS 159
TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 132 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 133 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 134 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 160
TABLE 135 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 136 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 161
9.4.3 CHINA 161
9.4.3.1 Healthcare infrastructure improvements in China to contribute to market growth 161
TABLE 137 CHINA: KEY MACROINDICATORS 162
TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 162
TABLE 139 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 140 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 141 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 163
TABLE 142 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 143 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 164
9.4.4 INDIA 164
9.4.4.1 Increasing demand for HCIT solutions to support market growth 164
TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 145 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 146 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 147 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 166
TABLE 148 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 149 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 167
9.4.5 AUSTRALIA AND NEW ZEALAND 167
9.4.5.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ 167
TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 168
TABLE 151 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 152 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 153 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 169
TABLE 154 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 155 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 170
9.4.6 SOUTH KOREA 170
9.4.6.1 Increasing medical tourism to boost market 170
TABLE 156 SOUTH KOREA: KEY MACROINDICATORS 171
TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 171
TABLE 158 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 159 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 160 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 172
TABLE 161 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 162 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 173
9.4.7 REST OF ASIA PACIFIC 173
TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174
TABLE 164 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 165 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 166 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 175
TABLE 167 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 168 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 175
9.5 LATIN AMERICA 176
9.5.1 FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH 176
9.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION 177
TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 177
TABLE 170 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 171 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 172 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 178
TABLE 173 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 174 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 179
9.6 MIDDLE EAST & AFRICA 179
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH 179
9.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION 180
TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 180
TABLE 176 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 177 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 178 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 181
TABLE 179 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 180 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 182
10 COMPETITIVE LANDSCAPE 183
10.1 OVERVIEW 183
10.2 KEY PLAYER STRATEGIES 183
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 184
10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS 186
10.4 REVENUE SHARE ANALYSIS 186
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS 187
10.5 MARKET SHARE ANALYSIS 187
FIGURE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021 188
10.6 COMPETITIVE BENCHMARKING 189
TABLE 181 COMPANY FOOTPRINT ANALYSIS 189
TABLE 182 PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES) 190
TABLE 183 END-USER FOOTPRINT ANALYSIS (25 COMPANIES) 191
TABLE 184 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES) 192
10.7 COMPANY EVALUATION QUADRANT, 2021 193
10.7.1 STARS 193
10.7.2 PERVASIVE PLAYERS 193
10.7.3 EMERGING LEADERS 193
10.7.4 PARTICIPANTS 193
FIGURE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021 194
10.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 195
10.8.1 PROGRESSIVE COMPANIES 195
10.8.2 DYNAMIC COMPANIES 195
10.8.3 RESPONSIVE COMPANIES 195
10.8.4 STARTING BLOCKS 195
FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 196
10.9 COMPETITIVE SCENARIO 197
10.9.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS 197
TABLE 185 INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020–2022 197
10.9.2 DEALS 197
TABLE 186 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020–2022 197
10.9.3 OTHER DEVELOPMENTS 199
TABLE 187 INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020–2022 199

ページTOPに戻る

Table of Contents

Summary

The infection surveillance solutions market is anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to increased demand the increasing prevalence of hospital-acquired infections, increasing surgical procedures, and rising healthcare expenditure among other factors. However, the Shortage of skilled healthcare IT professionals and Data security concerns are expected to limit the growth of this market to a certain extent. “Training & Consulting Services: The fastest-growing segment of the infection surveillance services market, by type“Training & consulting services are expected to witness the fastest growth in the infection surveillance services market during the forecast. Training and consulting services increase healthcare providers’ awareness of the latest infection surveillance solutions available in the market. Most large and mid-size companies actively provide technical assistance to hospitals, independent laboratories, and physician office laboratories that use infection surveillance software. Factors such as the increasing importance of value-based care, technological advancements, and growing consolidation in healthcare are driving the market for consulting services.“The large hospitals is anticipated to be the largest infection surveillance solutions market for hospitals, by type, during the forecast period”Based on type (the number of beds), hospitals are segmented into large (>450 beds), medium-sized (250–449 beds), and small (<249 beds) hospitals. The large hospitals segment accounted for the largest share of the infection surveillance solutions market for hospitals. The rising number of private hospitals in China and other developing countries is expected to drive the demand for technologically advanced HCIT solutions deployed in ICUs and other departments of hospitals. Furthermore, the complexity of managing HAIs rises with the size of hospitals, as more patients need to be monitored continuously; this is the primary reason for the large share of this end-user segment.“Europe accounted for the second-largest share in the infection surveillance solutions market during the forecast period”Europe accounted for the second-largest share of the infection surveillance solutions market during the forecast period. Growth in the European market can be attributed to the increasing adoption of HCIT solutions, the increasing incidence of HAIs, the increasing number of surgeries, and the rising geriatric population. The increasing need to improve patient outcomes has contributed to the adoption of infection surveillance solutions across the region. Several policies and guidelines have been implemented in Europe as infection prevention strategies for hospitals and long-term care facilities which are propelling the demand for infection surveillance solutions in the region.Break of primary participants was as mentioned below:• By Company Type – Tier 1–40%, Tier 2–35%, and Tier 3–25%• By Designation – C-level–35%, Director-level–25%, Others–40%• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%Key players in the Infection Surveillance Solutions MarketThe key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US).Research Coverage:The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies. Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.This report provides insights into the following pointers:• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by product & service and end user.• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market• Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（infection）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（infection）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?